AFP and hepatocellular carcinoma: Thirdly, while we demonstrated HCC-Check’s superiority over serum AFP, direct comparative analyses against the performance of standard imaging modalities (ultrasound, CT, MRI) or other relevant biomarkers like AFP-L3 and DCP were not conducted within this specific study cohort, primarily due to limitations in routine clinical availability for the latter.